Novartis IL-1 Beta Lung Cancer Prevention Pill
2 videos · score: 2,732 · first seen Jun 16, 2026
Novartis is developing an IL-1 beta-blocking pill that may prevent lung cancer by targeting inflammation — a YouTube nature video highlights its potential based on a cardiovascular trial finding, while other creators have not directly addressed the drug, keeping the discussion focused on its groundbreaking preventive approach.
A Second Nobel Prize for AlphaFold? 🧬🏆 #alphafold #deepmind #nobelprize #science #ai
John argues that AlphaFold's widespread adoption by over 3 million researchers could justify a second Nobel Prize due to its transformative impact on scientific research.
Could a pill prevent the world’s deadliest cancer?
Mount Sinai researchers, led by Dr. Tom Marron and Dr. Miriam Merad, are investigating a Novartis anti-inflammatory drug that blocks IL-1 beta after a serendipitous finding from a cardiovascular trial showed reduced lung cancer incidence, suggesting inflammation interception could prevent cancer initiation.